Orexo AB is a pharmaceutical company based in Sweden, with operations in the United States. The company focuses on USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline segments. The majority of its operations and revenue come from the USA Pharma segment, which commercializes fully owned pharmaceuticals in the US market. Digital Therapeutics focuses on innovative digital therapies in the US market, while HQ & Pipeline handles pharmaceutical development in Sweden. With a high ESG score of 38.9, Orexo AB is a leader in sustainability and governance within the pharmaceutical industry.